The safety and efficacy of acceptance and commitment therapy against psychotic symptomatology: a systematic review and meta-analysis
Autor: | Richard Gray, Monika Shrestha, Ellie Brown |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Psychosis Psychological intervention MEDLINE RC435-571 Review Article Acceptance and commitment therapy law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial systematic review law Medicine Effective treatment Humans Psychiatry business.industry medicine.disease ACT 030227 psychiatry acceptance and commitment therapy meta-analysis Psychiatry and Mental health Treatment Outcome Data extraction Psychotic Disorders Meta-analysis randomized controlled trial business 030217 neurology & neurosurgery RCT Clinical psychology |
Zdroj: | Brazilian Journal of Psychiatry Brazilian Journal of Psychiatry v.43 n.3 2021 Brazilian Journal of Psychiatry (São Paulo. 1999. Online) Associação Brasileira de Psiquiatria (ABP) instacron:ABP Brazilian Journal of Psychiatry, Vol 43, Iss 3, Pp 324-336 (2020) |
ISSN: | 1809-452X 1516-4446 |
Popis: | Objective Acceptance and commitment therapy (ACT) is a third-wave psychological intervention that has attracted considerable clinical and research attention. A previous meta-analysis of ACT trials in psychosis reported a large effect size of ACT against overall psychotic symptomatology. However, there were critical methodological issues in the review that justify replication. Methods Systematic review and meta-analysis of randomized controlled trials (RCTs) testing ACT vs. any comparator condition in a sample of adults with psychosis. The outcome of interest was overall psychotic symptomatology. Results The search identified seven published and eight unpublished trials (of which we were able to obtain data from one). Data on symptomatology were extracted from six trials that involved 274 participants. The summary effect size (Hedge's G) for overall symptomatology was small and not significant (-0.21, 95%CI -0.60-0.18). Trials were generally rated as having a high risk of bias. Safety reporting was inadequate across included trials. Conclusions Our observed effect size contrasted with that reported in a previous meta-analysis; differences were likely explained by errors in data extraction. The findings of this review suggest that there is currently inadequate evidence to conclude that ACT is a safe and effective treatment against psychotic symptomatology. Systematic review registration CRD42018097200. |
Databáze: | OpenAIRE |
Externí odkaz: |